Cleared Traditional

K830014 - HEMA - NV TRANS. BLOOD FILTER 100/800

K830014 is an FDA 510(k) clearance for HEMA - NV TRANS. BLOOD FILTER 100/800, manufactured by Abbott Laboratories. The device is a Class 2 General Hospital device with product code CAK cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K830014 · Abbott Laboratories · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1983
Decision
14d
Days
Class 2
Risk

K830014 is an FDA 510(k) clearance for the HEMA - NV TRANS. BLOOD FILTER 100/800. Classified as Microfilter, Blood Transfusion (product code CAK), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on January 17, 1983 after a review of 14 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K830014

510(k) Number K830014 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 03, 1983
Decision Date January 17, 1983
Days to Decision 14 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
115d faster than avg
Panel avg: 129d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAK Device Classification - Class 2, Special Controls

Product Code CAK Microfilter, Blood Transfusion
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - CAK Microfilter, Blood Transfusion

All 19
Devices cleared under the same product code (CAK) and FDA review panel - the closest regulatory comparables to K830014.
ERYPUR B
K864636 · Organon Teknika Corp. · Jan 1987
SWANK BLOOD TRANSFUSION MICRO-FILTER W/STRAIGHT SE
K855064 · Cobe Laboratories, Inc. · Mar 1986
20 MICRON HIGH CAPACITY TRANS/FILTER
K830057 · Travenol Laboratories, S.A. · Jan 1983
PEDIATRIC MICROAGGREGATE BLOOD FILTER
K812874 · Abbott Laboratories · Nov 1981
HEMA 20 MICRON TRANSFUSION BLOOD FILTER
K812697 · Abbott Laboratories · Oct 1981
ULTIPOR SQ40S BLOOD TRANSFUSION FILTER
K811985 · Pall Biomedical Products Co. · Jul 1981